T790M MUTATION ASSOCIATED WITH BETTER EFFICACY OF CONTINUOUS EGFR-TKI TREATMENT IN ADVANCED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI

被引：0
|
作者：
Ren, Shengxiang [1 ]
Li, Wei [2 ]
Li, Aiwu [3 ]
Chen, Xiaoxia [2 ]
Gao, Guanghui [2 ]
He, Yayi [4 ]
Li, Xuefei [5 ]
Zhou, Caicun [6 ]
机构：
[1] Tongji Univ, Shanghai Pulm Hosp, Shanghai, Peoples R China
[2] Tongji Univ, Dept Med Oncol, Affiliated Shanghai Pulm Hosp, Shanghai, Peoples R China
[3] Tongji Univ, Outpatient Dept, Affiliated Shanghai Pulm Hosp, Shanghai, Peoples R China
[4] Tongji Univ, Shanghai Pulm Hosp, Dept Med Oncol, Med Sch,Canc Inst, Shanghai, Peoples R China
[5] Tongji Univ, Dept Lung Canc & Immunol, Sch Med, Inst Canc, Shanghai, Peoples R China
[6] Tongji Univ, Dept Med Oncol, Lung Canc & Immunol Lab, Shanghai Pulm Hosp,Med Sch,Canc Inst, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
T790M mutation; NSCLC; Accquired resistance; Treatment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1084 / S1084
页数：1
相关论文
共 50 条
  • [1] T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients
    Li, Wei
    Ren, Shengxiang
    Li, Jiayu
    Li, Aiwu
    Fan, Lihong
    Li, Xuefei
    Zhao, Cao
    He, Yayi
    Gao, Guanghui
    Chen, Xiaoxia
    Li, Shuai
    Shi, Jingyun
    Zhou, Caicun
    Fei, Ke
    Schmid-Bindert, Gerald
    [J]. LUNG CANCER, 2014, 84 (03) : 295 - 300
  • [2] Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance
    D. Zheng
    X. Ye
    M. Z. Zhang
    Y. Sun
    J. Y. Wang
    J. Ni
    H. P. Zhang
    L. Zhang
    J. Luo
    J. Zhang
    L. Tang
    B. Su
    G. Chen
    G. Zhu
    Y. Gu
    J. F. Xu
    [J]. Scientific Reports, 6
  • [3] Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance
    Zheng, D.
    Ye, X.
    Zhang, M. Z.
    Sun, Y.
    Wang, J. Y.
    Ni, J.
    Zhang, H. P.
    Zhang, L.
    Luo, J.
    Zhang, J.
    Tang, L.
    Su, B.
    Chen, G.
    Zhu, G.
    Gu, Y.
    Xu, J. F.
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [4] Detection of the T790M Mutation of EGFR in Plasma of Advanced NSCLC Patients with Acquired Resistance to EGFR-TKI (WJOG8014LTR)
    Azuma, Koichi
    Takahama, Takayuki
    Sakai, Kazuko
    Takeda, Masayuki
    Hida, Toyoaki
    Hirabayashi, Masataka
    Oguri, Tetsuya
    Tanaka, Hiroshi
    Ebi, Noriyuki
    Sawa, Toshiyuki
    Bessho, Akihiro
    Tachihara, Motoko
    Akamatsu, Hiroaki
    Bandoh, Shuji
    Himeji, Daisuke
    Ohira, Tatsuo
    Shimokawa, Mototsugu
    Yamamoto, Nobuyuki
    Nakanishi, Yoichi
    Nakagawa, Kazuhiko
    Nishio, Kazuto
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S389 - S390
  • [5] A Comparison of ddPCR and ARMS for Detecting EGFR T790M Status from Advanced NSCLC Patients with Acquired EGFR-TKI Resistance
    Wang, Wenxian
    Song, Zhengbo
    Zhang, Yiping
    Jin, Ying
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1211 - S1211
  • [6] Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC
    Yang, Shuo
    Mao, Shiqi
    Li, Xuefei
    Zhao, Chao
    Liu, Qian
    Yu, Xiaofei
    Wang, Yan
    Liu, Yiwei
    Pan, Yingying
    Wang, Chunyan
    Gao, Guanghui
    Li, Wei
    Xiong, Anwen
    Chen, Bin
    Sun, Hui
    He, Yayi
    Wu, Fengying
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Zhou, Caicun
    [J]. LUNG CANCER, 2020, 139 : 133 - 139
  • [7] A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance
    Wang, Wenxian
    Song, Zhengbo
    Zhang, Yiping
    [J]. CANCER MEDICINE, 2017, 6 (01): : 154 - 162
  • [8] Association of plasma EGFR T790M ctDNA status with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance.
    Zheng, Di
    Ye, Xin
    Zhang, Meizhuo
    Sun, Yun
    Wang, Jiying
    Ni, Jian
    Zhang, Haiping
    Zhang, Ling
    Luo, Jie
    Zhang, Jie
    Tang, Liang
    Su, Bo
    Chen, Gang
    Zhu, Guanshan
    Gu, Yi
    Xu, Jianfang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Characterization of T790M According to Primary EGFR Mutation in Post EGFR-TKI Progression NSCLC in Brazil
    Ferreira, C.
    Zalis, M.
    Custodio, M.
    Montenegro, G.
    Zukin, M.
    Mathias, C.
    Haddad, C.
    Mascarenhas, E.
    Araujo, L.
    Montella, T.
    Da Silva, B.
    Bustamante, C.
    Muras, A.
    Reis, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S158 - S158
  • [10] Machine learning-based radiomics strategy for prediction of acquired EGFR T790M mutation following treatment with EGFR-TKI in NSCLC
    Lu, Jiameng
    Ji, Xiaoqing
    Liu, Xinyi
    Jiang, Yunxiu
    Li, Gang
    Fang, Ping
    Li, Wei
    Zuo, Anli
    Guo, Zihan
    Yang, Shuran
    Ji, Yanbo
    Lu, Degan
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
12345